doi: 10.1017/S0317167100046631 53 EideP
Neuroinflammation, Alzheimers, Parkinsons, and Cognition Neuroinflammation, Alzheimers, Parkinsons, and Cognition Emerging research is also showing promise for GLP-1 drugs in treatment of neurodegenerative diseases
It may help to remember that the needles used for GLP-1 medications are very thin and short, designed specifically for subcutaneous (under the skin) use rather than deep muscle injections
Preclinical studies have consistently shown that targeting ferroptosis with drugs such as iron chelators, lipid peroxidation inhibitors or NRF2 activators can produce significant neuroprotective effects
Dual-laser 808 and 1,064 nm strategy that circumvents the Achilles heel of photothermal therapy